146 related articles for article (PubMed ID: 377968)
1. Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
Lawson JS; Yuliano SE; Pasquale SA; Osterman JJ
Am J Obstet Gynecol; 1979 Jun; 134(3):315-20. PubMed ID: 377968
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
Corson SL
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with a new norgestimate-containing oral contraceptive.
Huber J
Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.
Hampton RM; Short M; Bieber E; Bouchard C; Ayotte N; Shangold G; Fisher AC; Creasy GW
Contraception; 2001 Jun; 63(6):289-95. PubMed ID: 11672549
[TBL] [Abstract][Full Text] [Related]
6. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Schoetzau A; Leese PT; Weidekamm E; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():4-11. PubMed ID: 21443598
[TBL] [Abstract][Full Text] [Related]
7. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
Rubio-Lotvin B; Gonzales-Ansorena R
Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of a low dose combined oral contraceptive ('Ovranette').
Foss GL; Fotherby K
Curr Med Res Opin; 1975; 3(2):72-6. PubMed ID: 1095309
[TBL] [Abstract][Full Text] [Related]
9. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
[TBL] [Abstract][Full Text] [Related]
10. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
11. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
Bifano M; Sevinsky H; Hwang C; Kandoussi H; Jiang H; Grasela D; Bertz R
Antivir Ther; 2014; 19(5):511-9. PubMed ID: 24343001
[TBL] [Abstract][Full Text] [Related]
12. Four years overall experience with a new low estrogen -- low progestogen oral contraceptive.
Brat T
Acta Obstet Gynecol Scand Suppl; 1976; 54():67-70. PubMed ID: 788448
[TBL] [Abstract][Full Text] [Related]
13. Fertility regulation using "triphasic" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 micrograms fixed dose regime.
Zador G
Acta Obstet Gynecol Scand Suppl; 1979; 88():43-8. PubMed ID: 393049
[No Abstract] [Full Text] [Related]
14. The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women.
Runnebaum B; Grunwald K; Rabe T
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1963-8. PubMed ID: 1605286
[TBL] [Abstract][Full Text] [Related]
15. Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
Davis A; Godwin A; Lippman J; Olson W; Kafrissen M
Obstet Gynecol; 2000 Dec; 96(6):913-20. PubMed ID: 11084177
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain.
Bye PG
Acta Obstet Gynecol Scand Suppl; 1976; 54():61-6. PubMed ID: 788447
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
LaGuardia KD; Shangold G; Fisher A; Friedman A; Kafrissen M
Contraception; 2003 Jun; 67(6):431-7. PubMed ID: 12814811
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of Rigevidon used for contraception].
Marianowski L; Grezechocińska B
Ginekol Pol; 1984 Aug; 55(8):631-5. PubMed ID: 6396173
[TBL] [Abstract][Full Text] [Related]
19. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
Hampton RM; Fisher AC; Pagano S; LaGuardia KD
Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
[TBL] [Abstract][Full Text] [Related]
20. Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel-ethinyl estradiol ratios.
Arnt IC; Ferrari A; Sartoretto JN; Woutersz TB
Fertil Steril; 1977 May; 28(5):549-53. PubMed ID: 323074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
